Xometry, Inc. (NASDAQ:XMTR) Released Earnings Last Week And Analysts Lifted Their Price Target To US$109
Xometry, Inc. Class A XMTR | 0.00 |
As you might know, Xometry, Inc. (NASDAQ:XMTR) just kicked off its latest second-quarter results with some very strong numbers. It looks like a positive result overall, with revenues of US$229m beating forecasts by 6.6%. Statutory losses of US$0.10 per share were 6.6% smaller than the analysts expected, likely helped along by the higher revenues. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.
Following the latest results, Xometry's nine analysts are now forecasting revenues of US$917.9m in 2026. This would be a solid 14% improvement in revenue compared to the last 12 months. Losses are predicted to fall substantially, shrinking 65% to US$0.19. Before this latest report, the consensus had been expecting revenues of US$876.4m and US$0.18 per share in losses. So it's pretty clear consensus is mixed on Xometry after the new consensus numbers; while the analysts lifted revenue numbers, they also administered a modest increase to per-share loss expectations.
It will come as a surprise to learn that the consensus price target rose 13% to US$109, with the analysts clearly more interested in growing revenue, even as losses intensify. The consensus price target is just an average of individual analyst targets, so - it could be handy to see how wide the range of underlying estimates is. There are some variant perceptions on Xometry, with the most bullish analyst valuing it at US$126 and the most bearish at US$95.00 per share. This is a very narrow spread of estimates, implying either that Xometry is an easy company to value, or - more likely - the analysts are relying heavily on some key assumptions.
These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the Xometry's past performance and to peers in the same industry. We can infer from the latest estimates that forecasts expect a continuation of Xometry'shistorical trends, as the 29% annualised revenue growth to the end of 2026 is roughly in line with the 25% annual growth over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to see their revenues grow 7.3% per year. So it's pretty clear that Xometry is forecast to grow substantially faster than its industry.
The Bottom Line
The most important thing to note is the forecast of increased losses next year, suggesting all may not be well at Xometry. Happily, they also upgraded their revenue estimates, and are forecasting them to grow faster than the wider industry. We note an upgrade to the price target, suggesting that the analysts believes the intrinsic value of the business is likely to improve over time.
Keeping that in mind, we still think that the longer term trajectory of the business is much more important for investors to consider. We have forecasts for Xometry going out to 2028, and you can see them free on our platform here.
That said, it's still necessary to consider the ever-present spectre of investment risk. We've identified 2 warning signs with Xometry , and understanding these should be part of your investment process.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
